• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《急诊成人癌症合并 COVID-19 感染患者院内死亡的预测因素:一项回顾性研究》。

"Predictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study".

机构信息

Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

出版信息

PLoS One. 2023 Jan 26;18(1):e0278898. doi: 10.1371/journal.pone.0278898. eCollection 2023.

DOI:10.1371/journal.pone.0278898
PMID:36701309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879530/
Abstract

BACKGROUND

Adult cancer patients are at higher risk of morbidity and mortality following COVID-19 infection. Being on the front lines, it is crucial for emergency physicians to identify those who are at higher risk of mortality. The aim of our study was to determine the predictors of in-hospital mortality in COVID-19 positive cancer patients who present to the emergency department.

METHODS

This is a retrospective cohort study conducted on adult cancer patients who presented to the ED of the American university of Beirut medical center from February 21, 2020, till February 21, 2021, and were found to have COVID-19 infection. Relevant data was extracted and analyzed. The association between different variables and in-hospital mortality was tested using Student's t test and Fisher's exact test or Pearson's Chi-square where appropriate. Logistic regression was applied to factors with p <0.2 in the univariate models.

RESULTS

The study included 89 distinct patients with an average age of 66 years (± 13.6). More than half of them were smokers (52.8%) and had received chemotherapy within 1 month of presentation (52.8%). About one third of the patients died (n = 31, 34.8%). Mortality was significantly higher in patients who had recently received chemotherapy (67.7% vs 44.8%, p = .039), a history of congestive heart failure (CHF)(p = .04), higher levels of CRP (p = 0.048) and/or PCT(p<0.04) or were tachypneic in the ED (P = 0.016).

CONCLUSIONS

Adult cancer patients with COVID-19 infection are at higher risks of mortality if they presented with tachypnea, had a recent chemotherapy, history of CHF, high CRP, and high procalcitonin levels at presentation.

摘要

背景

成年癌症患者在感染 COVID-19 后患病和死亡的风险更高。作为抗疫一线人员,急诊医生必须识别出那些死亡风险更高的患者。我们的研究目的是确定因 COVID-19 感染而就诊于急诊的成年癌症患者的院内死亡预测因子。

方法

这是一项回顾性队列研究,纳入了 2020 年 2 月 21 日至 2021 年 2 月 21 日期间因 COVID-19 感染就诊于贝鲁特美国大学医学中心急诊部的成年癌症患者。提取并分析了相关数据。使用 Student's t 检验、Fisher 确切检验或 Pearson 卡方检验(适当情况下)来检验不同变量与院内死亡率之间的关联。对单变量模型中 p<0.2 的因素应用逻辑回归。

结果

本研究纳入了 89 例不同的患者,平均年龄为 66 岁(±13.6)。超过一半的患者为吸烟者(52.8%),且在就诊前 1 个月内接受过化疗(52.8%)。约三分之一的患者死亡(n=31,34.8%)。近期接受化疗(67.7% vs 44.8%,p=0.039)、充血性心力衰竭(CHF)病史(p=0.04)、CRP 水平较高(p=0.048)和/或 PCT(p<0.04)或就诊时呼吸急促的患者死亡率显著更高(p=0.016)。

结论

因 COVID-19 感染就诊的成年癌症患者如果就诊时呼吸急促、近期接受化疗、有 CHF 病史、CRP 和降钙素原水平较高,则死亡风险更高。

相似文献

1
"Predictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study".《急诊成人癌症合并 COVID-19 感染患者院内死亡的预测因素:一项回顾性研究》。
PLoS One. 2023 Jan 26;18(1):e0278898. doi: 10.1371/journal.pone.0278898. eCollection 2023.
2
Predictors of intensive care unit admission in adult cancer patients presenting to the emergency department with COVID-19 infection: A retrospective study.COVID-19 感染成人癌症患者就诊于急诊科入住重症监护病房的预测因素:一项回顾性研究。
PLoS One. 2023 Aug 29;18(8):e0287649. doi: 10.1371/journal.pone.0287649. eCollection 2023.
3
High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.血清降钙素原水平与急诊科 COVID-19 感染患者入住重症监护病房和死亡风险增加相关。
BMC Infect Dis. 2022 Feb 21;22(1):165. doi: 10.1186/s12879-022-07144-5.
4
Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.降钙素原浓度在急诊科预测 COVID-19 30 天死亡率优于淋巴细胞计数、中性粒细胞与淋巴细胞比值或 C 反应蛋白水平。
Emergencias. 2022 Apr;34(2):119-127.
5
Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.在因 COVID-19 而到急诊科就诊的成年患者中,细菌学检测的诊断效果及其导致重症的预测因子。
Emerg Med J. 2021 Sep;38(9):685-691. doi: 10.1136/emermed-2020-211027. Epub 2021 Jul 21.
6
Outcomes of patients with systolic heart failure presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon.以黎巴嫩一家三级医院的急诊就诊的收缩性心力衰竭伴脓毒症患者的结局:一项回顾性图表审查研究。
BMJ Open. 2018 Aug 1;8(7):e022185. doi: 10.1136/bmjopen-2018-022185.
7
Patterns and predictors of early mortality among emergency department patients in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴急诊科患者早期死亡的模式及预测因素
BMC Res Notes. 2015 Oct 24;8:605. doi: 10.1186/s13104-015-1592-z.
8
Lack of admission biomarkers' clinical utility in outcomes prediction in patients suspected with infection in the emergency department.缺乏入院生物标志物在急诊科疑似感染患者结局预测中的临床实用性。
Am J Emerg Med. 2021 Sep;47:109-114. doi: 10.1016/j.ajem.2021.03.050. Epub 2021 Mar 26.
9
Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room.来自癌症专科急诊室的 COVID-19 患者的结局。
Cancer Invest. 2022 Jan;40(1):17-25. doi: 10.1080/07357907.2021.1985134. Epub 2021 Oct 28.
10
Clinical characteristics and management of COVID-19 patients accessing the emergency department in a hospital in Northern Italy in March and April 2020.2020 年 3 月至 4 月意大利北部一家医院急诊科就诊的 COVID-19 患者的临床特征和管理。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):208-215. doi: 10.19191/EP20.5-6.S2.120.

引用本文的文献

1
Rapid dynamic changes of FL.2 variant: A case report of COVID-19 breakthrough infection.FL.2 变异株快速动态变化:COVID-19 突破性感染病例报告。
Int J Infect Dis. 2024 Jan;138:91-96. doi: 10.1016/j.ijid.2023.11.011. Epub 2023 Nov 11.

本文引用的文献

1
How Will COVID-19 Affect the Health Care Economy?新冠病毒将如何影响医疗保健经济?
JAMA Health Forum. 2020 Apr 1;1(4):e200419. doi: 10.1001/jamahealthforum.2020.0419.
2
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?癌症与 COVID-19:为什么癌症患者更容易感染 COVID-19?
Med Oncol. 2021 Jul 24;38(9):101. doi: 10.1007/s12032-021-01553-3.
3
The signal pathways and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的信号通路与治疗策略。
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0.
4
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).COVID-19 患者的癌症结局:来自国家 COVID 队列协作 (N3C) 的报告。
J Clin Oncol. 2021 Jul 10;39(20):2232-2246. doi: 10.1200/JCO.21.01074. Epub 2021 Jun 4.
5
Admission respiratory status predicts mortality in COVID-19.入院时的呼吸状况可预测 COVID-19 患者的死亡率。
Influenza Other Respir Viruses. 2021 Sep;15(5):569-572. doi: 10.1111/irv.12869. Epub 2021 May 24.
6
A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.新型冠状病毒感染癌症患者的系统评价和荟萃分析。
JNCI Cancer Spectr. 2021 Feb 24;5(2):pkaa102. doi: 10.1093/jncics/pkaa102. eCollection 2021 Apr.
7
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.癌症患者 COVID-19 严重程度与临床因素和近期抗癌治疗的相关性:来自 COVID-19 和癌症联合会的报告。
Ann Oncol. 2021 Jun;32(6):787-800. doi: 10.1016/j.annonc.2021.02.024. Epub 2021 Mar 19.
8
Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis.充血性心力衰竭对 COVID-19 患者的影响及心脏生物标志物的作用:系统评价和荟萃分析。
Indian Heart J. 2021 Jan-Feb;73(1):91-98. doi: 10.1016/j.ihj.2020.12.002. Epub 2020 Dec 6.
9
The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.抗癌治疗对合并 COVID-19 的癌症患者的影响:系统评价和荟萃分析。
Cancer Med. 2021 Feb;10(3):1043-1056. doi: 10.1002/cam4.3692. Epub 2020 Dec 31.
10
Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.癌症患者与 COVID-19:死亡率、严重并发症、生物标志物和前进方向。
Cancer Treat Res Commun. 2021;26:100285. doi: 10.1016/j.ctarc.2020.100285. Epub 2020 Dec 13.